Pressure BioSciences, Inc. (PBIO)
- Previous Close
0.2300 - Open
0.2300 - Bid --
- Ask --
- Day's Range
0.2139 - 0.2300 - 52 Week Range
0.1400 - 1.0400 - Volume
23,368 - Avg. Volume
90,577 - Market Cap (intraday)
5.663M - Beta (5Y Monthly) -0.07
- PE Ratio (TTM)
-- - EPS (TTM)
-1.5800 - Earnings Date May 14, 2024 - May 20, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.
www.pressurebiosciences.comRecent News: PBIO
Performance Overview: PBIO
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PBIO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PBIO
Valuation Measures
Market Cap
5.66M
Enterprise Value
26.86M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.79
Price/Book (mrq)
--
Enterprise Value/Revenue
11.82
Enterprise Value/EBITDA
-4.77
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-212.70%
Return on Equity (ttm)
--
Revenue (ttm)
2.27M
Net Income Avi to Common (ttm)
-29.56M
Diluted EPS (ttm)
-1.5800
Balance Sheet and Cash Flow
Total Cash (mrq)
5.26k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-15.02M
Company Insights: PBIO
PBIO does not have Company Insights